Skip to main content

Month: March 2025

BIO-key Completes Initial Biometric-Based Identity and Access Management Deployment for New International Defense Agency Customer in Record Time

Solution Features PortalGuard On-Prem, WEB-key Biometric Software, FIPS Certified Fingerprint Scanners, and Passkey:YOU FIDO2 Passkeys MADRID, Spain and HOLMDEL, N.J., March 26, 2025 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication solutions has successfully completed the deployment of a comprehensive suite of BIO-key biometric-based IAM solutions for a new International Defense Agency customer. The full deployment for the initial sites was completed in just four days, showcasing the efficiency, seamless integration, and collaboration between BIO-key and the customer’s IT team. The deployment incorporates these BIO-key solutions:PortalGuard On-Prem – A highly secure IAM platform providing Multi-factor Authentication (MFA) and Single...

Continue reading

Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting

Additional data from the MDNA11 ABILITY-1 trial to be presented at the Annual Meeting Pre-clinical data on Medicenna’s first-in-class Masked and Tumor Targeted Bifunctional anti-PD1-IL2 Superkine, MDNA113, will also be presented TORONTO and HOUSTON, March 26, 2025 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune diseases, announced today that two posters will be presented at the American Association for Cancer Research Annual Meeting 2025 (AACR 2025) taking place April 25-30, 2025 in Chicago, Illinois. The Company will present an update from its Phase 1/2 ABILITY-1 Study evaluating MDNA11, the only long-acting, ‘beta-enhanced not-alpha’ interleukin-2 (IL-2) super-agonist...

Continue reading

Trident Announces Strategic Collaboration with Two Global E-Commerce Firms

Trident’s strategic collaboration with e-commerce players Silkoo and Haitu will combine their unique strengths to drive innovation and mutual growth SINGAPORE, March 26, 2025 (GLOBE NEWSWIRE) — Trident Digital Tech Holdings Ltd (“Trident” or the “Company,” NASDAQ: TDTH), a leading catalyst for digital transformation in technology optimization services and Web 3.0 activation based in Singapore, today announced it has entered into a strategic collaboration agreement (the “Collaboration Agreement”) with two partners in the e-commerce sector. Per the Collaboration Agreement, Trident will join forces with Silkoo Dutyfree Limited (“Silkoo”), an e-commerce retailer and import-export trader, and Haitu Trade Co., Limited (“Haitu”), an e-commerce entity specializing in beauty and cosmetics, to foster a synergistic partnership that drives...

Continue reading

Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress

MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is being studied in multiple Phase 2b clinical trials with read-outs beginning mid-2025 Multiple data readouts in mid and late 2025 on track for MET-233i, an ultra-long acting amylin analog currently in Phase 1 Oral formulation optimization study on track to support initiation of clinical trials for MET-224o and MET097o, with MET-224o data expected in late 2025 Completed IPO with gross proceeds of approximately $316.2 million, extending runway into 2027 NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Metsera, Inc. (Nasdaq: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today reported fourth quarter and full year 2024 financial results and provided an update on pipeline progress. “2024...

Continue reading

PyroGenesis Schedules 2024 Fiscal Year Financial Results and Business Update Conference Call

MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) — PyroGenesis Inc. (“PyroGenesis”) (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company that designs, develops, manufactures and commercializes advanced all-electric plasma processes and sustainable solutions to support heavy industry in their energy transition, emission reduction, commodity security, and waste remediation efforts, today announces that it will host a conference call at 10:00 AM Eastern Time on Tuesday, April 1st, 2025 to discuss the Company’s financial results for the fiscal year 2024 which ended December, 31, 2024, as well as provide an update to the Company’s progress and other developments. To access the conference call by telephone, please pre-register using the following link: https://register-conf.media-server.com/register/BI4309c0c8634741c9bf5b19154e79ce09....

Continue reading

Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights

Company reports fourth quarter and full year 2024 XHANCE net revenue of $22.4 million and $78.2 million, increases of 13% and 10% compared to prior year periods Company reports 23% prescription growth from third quarter 2024 to fourth quarter 2024 YARDLEY, Pa., March 26, 2025 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial results for the quarter and year ended December 31, 2024, and provided recent operational highlights. Fourth Quarter 2024 and Recent Highlights New Prescriptions (NRx) and Total Prescriptions (TRx)An inflection in prescription demand first observed in September 2024 NRx continued in fourth quarter 2024 and extended to TRx. NRx increased 12% from approximately 25,600 in third quarter...

Continue reading

SailPoint Announces Strong Fiscal Fourth Quarter and Full Year 2025 Financial Results

Grew ARR 29% year-over-year to $877 million Expanded SaaS ARR 39% year-over-year to $540 million Finished the year with an ~80% year-over-year increase in the number of customers with more than $1 million of ARRAUSTIN, Texas, March 26, 2025 (GLOBE NEWSWIRE) — SailPoint, Inc. (Nasdaq: SAIL), a leader in enterprise identity security, today announced financial results for its fiscal fourth quarter and full year, ended January 31, 2025. “We are very pleased to report our strong fourth quarter and full year 2025 results where our continued pursuit of efficient growth at scale drove a year of greater than ‘rule of 40’ performance. Our relentless focus on innovation and execution enables us to capitalize on the growing market opportunity to help enterprises as they struggle to manage, govern and secure their vast identity landscape,”...

Continue reading

Mawson Infrastructure Group Inc. Executes New Customer Agreement with Canaan Inc., Growing and Expanding Digital Colocation Business with Latest-Gen ASICs

MIDLAND, Pa., March 26, 2025 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson” or “the Company”), a publicly-traded technology company focused on digital infrastructure platforms for artificial intelligence (AI), high-performance computing (HPC), and digital assets markets, today announced that it has signed a significant new digital colocation customer agreement with Canaan Inc., a NASDAQ-listed publicly traded company (NASDAQ: CAN), further growing and expanding its digital colocation business with latest-generation application-specific integrated circuit machines (ASICs). The new customer colocation agreement executed between Mawson’s President and CEO Rahul Mewawalla and Canaan’s Chairman and CEO Nangeng Zhang on March 21, 2025 is for Mawson to provide Canaan with digital colocation services for about...

Continue reading

Madis Toomsalu expresses will to resign as CEO of LHV Group

Madis Toomsalu, the Chairman of the Management Board of AS LHV Group, has informed the company’s Nomination Commitee and the Supervisory Board of his will to resign by the fall of this year. Preparations are underway to find a new Chairman of the Board for the financial group. Mr Toomsalu has worked in LHV since 2007 when he arrived as an intern. He became the first credit analyst in LHV Pank and afterwards led the field as Head of Credits and Chairman of the Credit Committee. Since 2016 he has held the position of Chairman of the Management Board of LHV Group. Additionally he is the Chairman of the Supervisory Boards of AS LHV Pank, AS LHV Kindlustus, AS LHV Varahaldus and the Chairman of the Board of Directors of LHV Bank Ltd.  Under his leadership LHV’s loan portfolio has increased tenfold, reaching nearly EUR 5 billion today....

Continue reading

Taboola Announces Q1 2025 Tracking to High End of Guidance Ranges Across All Key Metrics

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced that its first quarter 2025 results are tracking toward the high end of the previously disclosed guidance ranges for Revenues, Gross profit, ex-TAC Gross Profit, and Adjusted EBITDA. The company expects to report its first quarter 2025 results before the market opens on Wednesday, May 7, 2025. The indications for the metrics in this press release are preliminary, unaudited and subject to change. Upcoming Investor Day Taboola will be hosting its Investor Day later today, March 26, 2025 at 10:00 a.m. ET. The Investor Day webcast can be accessed through Taboola’s website at investors.taboola.com. About TaboolaTaboola empowers businesses to grow through performance advertising technology...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.